エーザイ、中心循環系血管内塞栓促進用補綴材「ディーシービーズ」使用目的又は効果の一部削除の承認について

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

2018年09月03日 16時00分

Source: Eisai

エーザイ、中心循環系血管内塞栓促進用補綴材「ディーシービーズ」使用目的又は効果の一部削除の承認について

東京, 2018年09月03日 - (JCN Newswire) - エーザイ株式会社（本社：東京都、代表執行役CEO：内藤晴夫）は、このたび、日本において、中心循環系血管内塞栓促進用補綴材「ディーシービーズ(R)」（高度管理医療機器、以下本品）について、使用目的又は効果の一部削除が承認され、使用目的又は効果が「多血性腫瘍（子宮筋腫を除く）を有する患者に対する動脈塞栓療法」となりましたことをお知らせします。

今回の使用目的又は効果の一部削除の承認は、実臨床上、本品は「子宮筋腫」及び「動静脈奇形」に対して使用されないことから、関連学会に確認の上、当局と相談し、当該適応に係る使用目的又は効果の取り下げの一部変更承認申請を行っていたことに基づくものです。

当社は、本使用目的又は効果の一部削除に際し、医療関係者の皆様への適切な情報提供に努めてまいります。

本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2018/news201876.html

概要：エーザイ株式会社

詳細は www.eisai.co.jp をご覧ください。

Source: Eisai
セクター: バイオテック

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

Toyota Motor Corporation

TOYOTA GAZOO Racing reinforces WRC line-up with youth and experience for 2025
Nov 25, 2024 17:10 JST

Toyota Motor Corporation

Toyota Submits Progress Report on Recurrence Prevention Measures
Nov 25, 2024 15:43 JST

Mitsubishi Heavy Industries, Ltd.

MHI Thermal Systems Receives Order from Aisan Industry for Aquifer Thermal Energy Storage System for Its New Anjo Plant
Nov 25, 2024 14:18 JST

Honda Motor Co, Ltd

Oracle Red Bull Racing Driver Max Verstappen Wins Fourth Consecutive F1 Drivers' World Championship
Nov 25, 2024 11:55 JST

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST

NaaS Technology Inc.

NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST

Honda Motor Co, Ltd

Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST

Lexaria Bioscience

ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST

Mitsubishi Heavy Industries, Ltd.

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST

Eisai

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST

Eisai

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST

Kingsoft Corporation Limited

Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST

Olympus

NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST

Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST

CleverTap

CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST

NEC Corporation

World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST

Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST

Toyota Motor Corporation

Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST

COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST

More Latest Release >>